Evaluation of the Octreotide Acetate Pen Injector and its Instructions for Use in a Formative Human Factors Study

INTRODUCTION: Octreotide acetate subcutaneous injection is indicated to treat acromegaly and the symptoms of carcinoid tumors and vasoactive intestinal peptide tumors (VIPomas). This formative human factors study assessed the octreotide acetate pen injector and accompanying instructions for use (IFU...

Descripción completa

Detalles Bibliográficos
Autores principales: Andre, Anthony, Squittieri, Nicholas, Patil, Satyashodhan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189973/
https://www.ncbi.nlm.nih.gov/pubmed/33948925
http://dx.doi.org/10.1007/s12325-021-01739-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189973/
https://www.ncbi.nlm.nih.gov/pubmed/33948925
http://dx.doi.org/10.1007/s12325-021-01739-1

Ejemplares similares